MedPath

acyclovir

ACYCLOVIR TABLETS, USP 400 mg and 800 mg

Approved
Approval ID

b2ae0432-bd2a-1480-e053-2a95a90a6fc8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 14, 2022

Manufacturers
FDA

NuCare Pharmaceuticals,Inc.

DUNS: 010632300

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

acyclovir

PRODUCT DETAILS

NDC Product Code68071-2287
Application NumberANDA077309
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateJanuary 14, 2022
Generic Nameacyclovir

INGREDIENTS (5)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
ACYCLOVIRActive
Quantity: 400 mg in 1 1
Code: X4HES1O11F
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

acyclovir - FDA Drug Approval Details